Drug Profile
ZD 8731
Alternative Names: ICI D 8731Latest Information Update: 06 Sep 2000
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antihyperglycaemics; Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic cardiomyopathy; Heart failure; Hypertension
Most Recent Events
- 06 Sep 2000 Discontinued-Preclinical for Diabetic cardiomyopathy in United Kingdom (Unknown route)
- 07 Apr 1999 Merger of Zeneca and Astra to form AstraZeneca completed
- 16 Nov 1998 No-Development-Reported for Diabetic cardiomyopathy in United Kingdom (Unknown route)